John Breton - Concepedia

Author

John Breton

Also Known As

J J Breton, J. Breton, J. J. BRETON, J.J. Breton, JOHN J. BRETON, John Breton, John J Breton, John J. BRETON, John J. Breton, John Jeffrey Breton

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

New Frontier GlaxoSmithKline (United States)Medicines for Malaria Venture GlaxoSmithKline (United Kingdom)Fundação de Medicina Tropical

About

John Breton is an author at New Frontier specializing in medicine, pharmacology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	699
2	Biochemistry	5	5	219
3	Natural Sciences	4	4	209
4	Allergy	3	3	249
5	Health Sciences	1	1	41

John Breton

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Single-Dose Tafenoquine to Prevent Relapse of <i>Plasmodium vivax</i> Malaria Marcus Lacerda, Alejandro Llanos‐Cuentas, Srivicha Krudsood, New England Journal of Medicine	2019	277
Tafenoquine versus Primaquine to Prevent Relapse of <i>Plasmodium vivax</i> Malaria Alejandro Llanos‐Cuentas, Marcus Lacerda, Tran Tinh Hien, New England Journal of Medicine	2019	239
1-Substituted 4-Aryl-5-pyridinylimidazoles: A New Class of Cytokine Suppressive Drugs with Low 5-Lipoxygenase and Cyclooxygenase Inhibitory Potency Jeffrey C. Boehm, Juanita M. Smietana, Margaret E. Sorenson, Journal of Medicinal Chemistry Aa Rat ModelLipid PeroxidationImmunologyCell DeathPharmacotherapy	1996	120
Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis C. Meurot, C. Martin, L. Sudre, Scientific Reports	2022	114
Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response Don E. Griswold, Edward F. Webb, John Breton, Inflammation InflammationCellular PhasesAnti-inflammatoryAutoimmune DiseaseMedicine	1993	87
Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: Results of a randomized controlled trial Lawrence Charles Parish, Joseph L. Jorizzo, John Breton, Journal of the American Academy of Dermatology AllergyTopical Retapamulin OintmentOral CephalexinTopical DrugContact Dermatitis	2006	71
Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): two randomised, controlled, double-blind, double-dummy, phase 3, non-inferiority trials Florian Wagenlehner, Caroline Perry, Thomas M. Hooton, The Lancet UrologyAntimicrobial StewardshipAntibioticsPharmacotherapyAntimicrobial Chemotherapy	2024	66
The natural product hymenialdisine inhibits interleukin-8 production in U937 cells by inhibition of nuclear factor-kappaB. John Breton, Marie Chabot‐Fletcher PubMed Il-8 ProductionImmune RegulationImmunologyIl-8 Mrna FormationInnate Immunity	1997	58
Characterization of peptidyl boronic acid inhibitors of mammalian 20 S and 26 S proteasomes and their inhibition of proteasomes in cultured cells Robert C. Gardner, Stephen J. Assinder, Gary Christie, Biochemical Journal Cultured CellsMedicinal ChemistryBiochemistryMedicineNatural Sciences	2000	53
Efficacy and Safety of Pharmacokinetically Enhanced Amoxicillin-Clavulanate at 2,000/125 Milligrams Twice Daily for 5 Days versus Amoxicillin-Clavulanate at 875/125 Milligrams Twice Daily for 7 Days in the Treatment of Acute Exacerbations of Chronic Bronchitis Sanjay Sethi, John Breton, Brian Wynne Antimicrobial Agents and Chemotherapy Milligrams Twice DailyPharmacotherapyAntimicrobial ChemotherapyDrug ResistanceChronic Bronchitis	2004	41

Page 1